Published in J Cancer on September 26, 2012
Current Challenges in Volatile Organic Compounds Analysis as Potential Biomarkers of Cancer. J Biomark (2015) 0.87
Application of metabolomics in thyroid cancer research. Int J Endocrinol (2015) 0.84
Hallmarks of cancer: the next generation. Cell (2011) 140.01
Cancer statistics, 2012. CA Cancer J Clin (2012) 87.38
Surfing the p53 network. Nature (2000) 35.36
Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther (2001) 14.78
Metabolomics--the link between genotypes and phenotypes. Plant Mol Biol (2002) 11.36
AMP-activated protein kinase induces a p53-dependent metabolic checkpoint. Mol Cell (2005) 11.19
Tumor cell metabolism: cancer's Achilles' heel. Cancer Cell (2008) 11.18
Phases of biomarker development for early detection of cancer. J Natl Cancer Inst (2001) 10.37
Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance. Cancer Cell (2006) 9.80
Akt stimulates aerobic glycolysis in cancer cells. Cancer Res (2004) 9.35
The case for early detection. Nat Rev Cancer (2003) 6.96
HIF-1 inhibits mitochondrial biogenesis and cellular respiration in VHL-deficient renal cell carcinoma by repression of C-MYC activity. Cancer Cell (2007) 6.06
Rational, biologically based treatment of EGFR-mutant non-small-cell lung cancer. Nat Rev Cancer (2010) 5.82
c-Myc transactivation of LDH-A: implications for tumor metabolism and growth. Proc Natl Acad Sci U S A (1997) 5.43
Pyruvate kinase type M2 and its role in tumor growth and spreading. Semin Cancer Biol (2005) 5.25
Oncogenic alterations of metabolism. Trends Biochem Sci (1999) 4.51
Energy substrate modulates mitochondrial structure and oxidative capacity in cancer cells. Cancer Res (2004) 4.03
Selection and interpretation of diagnostic tests and procedures. Principles and applications. Ann Intern Med (1981) 3.85
Roadmap for developing and validating therapeutically relevant genomic classifiers. J Clin Oncol (2005) 3.82
Volatile organic compounds in breath as markers of lung cancer: a cross-sectional study. Lancet (1999) 3.70
Quantitative analysis of urine vapor and breath by gas-liquid partition chromatography. Proc Natl Acad Sci U S A (1971) 3.14
A comprehensive urinary metabolomic approach for identifying kidney cancerr. Anal Biochem (2007) 3.14
Cancer: Inflaming metastasis. Nature (2009) 3.09
Detection of lung cancer with volatile markers in the breath. Chest (2003) 3.09
Orlistat is a novel inhibitor of fatty acid synthase with antitumor activity. Cancer Res (2004) 2.43
EML4-ALK: honing in on a new target in non-small-cell lung cancer. J Clin Oncol (2009) 2.39
Cancer biomarkers: can we turn recent failures into success? J Natl Cancer Inst (2010) 2.29
The bioenergetic signature of cancer: a marker of tumor progression. Cancer Res (2002) 2.24
Molecular pathways in invasive bladder cancer: new insights into mechanisms, progression, and target identification. J Clin Oncol (2006) 2.14
Diagnostic potential of breath analysis--focus on volatile organic compounds. Clin Chim Acta (2004) 2.12
Serum metabolite profiling of human colorectal cancer using GC-TOFMS and UPLC-QTOFMS. J Proteome Res (2009) 2.10
Metabolite profiling of human colon carcinoma--deregulation of TCA cycle and amino acid turnover. Mol Cancer (2008) 2.02
Metabonomics technologies and their applications in physiological monitoring, drug safety assessment and disease diagnosis. Biomarkers (2004) 1.79
Pathway analysis of kidney cancer using proteomics and metabolic profiling. Mol Cancer (2006) 1.78
Neurochemical monitoring using intracerebral microdialysis in patients with subarachnoid hemorrhage. J Neurosurg (1996) 1.75
Chemical monitoring of neurosurgical intensive care patients using intracerebral microdialysis. J Neurosurg (1992) 1.64
Prediction of lung cancer using volatile biomarkers in breath. Cancer Biomark (2007) 1.60
Volatile biomarkers of pulmonary tuberculosis in the breath. Tuberculosis (Edinb) (2006) 1.57
Sugar and fat - that's where it's at: metabolic changes in tumors. Breast Cancer Res (2008) 1.49
Magnetic resonance spectroscopy. J Neuroophthalmol (2005) 1.47
Determination of acetone in human breath by gas chromatography-mass spectrometry and solid-phase microextraction with on-fiber derivatization. J Chromatogr B Analyt Technol Biomed Life Sci (2004) 1.36
Clinical relevance of KRAS in human cancers. J Biomed Biotechnol (2010) 1.34
Baseline levels of glucose metabolites, glutamate and glycerol in malignant glioma assessed by stereotactic microdialysis. J Neurooncol (2003) 1.31
Metabolomic profiling of human urine in hepatocellular carcinoma patients using gas chromatography/mass spectrometry. Anal Chim Acta (2009) 1.28
Exhaled breath analysis: novel approach for early detection of lung cancer. Lung Cancer (2008) 1.28
Mass spectrometry based metabolomic approaches in urinary biomarker study of women's cancers. Clin Chim Acta (2008) 1.27
Noninvasive urinary metabonomic diagnosis of human bladder cancer. J Proteome Res (2010) 1.26
Prediction of breast cancer using volatile biomarkers in the breath. Breast Cancer Res Treat (2006) 1.26
Method for the collection and assay of volatile organic compounds in breath. Anal Biochem (1997) 1.24
A computerized classification technique for screening for the presence of breath biomarkers in lung cancer. Clin Chem (1988) 1.23
Recent advances in biomarkers for cancer diagnosis and treatment. Drug Discov Today (2005) 1.23
Quantitative breath analysis of volatile organic compounds of lung cancer patients. Lung Cancer (2009) 1.21
Metabolomics of cancer. Methods Mol Biol (2009) 1.21
Detection of lung cancer using weighted digital analysis of breath biomarkers. Clin Chim Acta (2008) 1.21
Hypoxia-inducible factor 1 (HIF-1) in cancer. Eur J Surg Oncol (2004) 1.14
Recent and potential developments of biofluid analyses in metabolomics. J Proteomics (2011) 1.11
The analysis of healthy volunteers' exhaled breath by the use of solid-phase microextraction and GC-MS. J Breath Res (2008) 1.10
Colorectal cancer screening by non-invasive metabolic biomarker fecal tumor M2-PK. World J Gastroenterol (2006) 1.09
Breath biomarkers for lung cancer detection and assessment of smoking related effects--confounding variables, influence of normalization and statistical algorithms. Clin Chim Acta (2010) 1.07
Determination of aldehydes in exhaled breath of patients with lung cancer by means of on-fiber-derivatisation SPME-GC/MS. J Chromatogr B Analyt Technol Biomed Life Sci (2010) 1.06
Immunohistological demonstration of the same type of pyruvate kinase isoenzyme (M2-Pk) in tumors of chicken and rat. Virchows Arch B Cell Pathol Incl Mol Pathol (1981) 1.06
Effect of oxygen on breath markers of oxidative stress. Eur Respir J (2003) 1.04
1H NMR spectra of normal urines: reference ranges of the major metabolites. Clin Chim Acta (1997) 1.00
Metabolomics of gastric cancer metastasis detected by gas chromatography and mass spectrometry. World J Gastroenterol (2010) 0.99
Metabolomic patterns in glioblastoma and changes during radiotherapy: a clinical microdialysis study. J Proteome Res (2010) 0.97
Effect of age on the breath methylated alkane contour, a display of apparent new markers of oxidative stress. J Lab Clin Med (2000) 0.95
Identification of volatile organic compounds secreted from cancer tissues and bacterial cultures. J Chromatogr B Analyt Technol Biomed Life Sci (2008) 0.93
Prediction of heart transplant rejection with a breath test for markers of oxidative stress. Am J Cardiol (2004) 0.92
Fluorescein electronic endoscopy: a novel method for detection of early stage gastric cancer not evident to routine endoscopy. Gastrointest Endosc (2002) 0.92
Distribution of BPA and metabolic assessment in glioblastoma patients during BNCT treatment: a microdialysis study. J Neurooncol (2005) 0.89
Glucose metabolites, glutamate and glycerol in malignant glioma tumours during radiotherapy. J Neurooncol (2008) 0.89
Gas chromatography-mass spectrometric analysis of hexanal and heptanal in human blood by headspace single-drop microextraction with droplet derivatization. Anal Biochem (2005) 0.88
Chemical carcinogenesis. An Acad Bras Cienc (2007) 0.88
Clinical significance of BRAF gene mutations in patients with non-small cell lung cancer. Anticancer Res (2011) 0.87
Breast-cancer screening with ultrasonography. Lancet (2000) 0.87
Metabotyping of human colorectal cancer using two-dimensional gas chromatography mass spectrometry. Anal Bioanal Chem (2012) 0.86
Prognostic impact of AMP-activated protein kinase expression in ovarian carcinoma: correlation of protein expression and GC/TOF-MS-based metabolomics. Oncol Rep (2011) 0.86
Automated needle trap heart-cut GC/MS and needle trap comprehensive two-dimensional GC/TOF-MS for breath gas analysis in the clinical environment. Anal Chem (2010) 0.85
Identification of possible biomarkers for breast cancer from free fatty acid profiles determined by GC-MS and multivariate statistical analysis. Clin Biochem (2011) 0.84
Informatics for cross-sample analysis with comprehensive two-dimensional gas chromatography and high-resolution mass spectrometry (GCxGC-HRMS). Talanta (2010) 0.84
Fuzzy logic-based tumor marker profiles including a new marker tumor M2-PK improved sensitivity to the detection of progression in lung cancer patients. Anticancer Res (2003) 0.83
Comprehensive two-dimensional gas chromatography in metabolomics. Anal Bioanal Chem (2012) 0.83
What is the 'normal range' for prostate-specific antigen? Use of a receiver operating characteristic curve to evaluate a serum marker. Br J Urol (1995) 0.82
Determination of volatile organic compounds in human breath for Helicobacter pylori detection by SPME-GC/MS. Biomed Chromatogr (2011) 0.81
Spreading evaluation in primitive bronchogenic carcinoma: benefit of cerebral MRI compared to CT scan. Eur J Cancer (1995) 0.78
Metabolic profiling of infant urine using comprehensive two-dimensional gas chromatography: Application to the diagnosis of organic acidurias and biomarker discovery. J Chromatogr A (2009) 0.77
Accelerating analysis for metabolomics, drugs and their metabolites in biological samples using multidimensional gas chromatography. Bioanalysis (2009) 0.76
One-pot microwave derivatization of target compounds relevant to metabolomics with comprehensive two-dimensional gas chromatography. J Chromatogr B Analyt Technol Biomed Life Sci (2010) 0.76
Anti-VEGF treatment reduces blood supply and increases tumor cell invasion in glioblastoma. Proc Natl Acad Sci U S A (2011) 3.48
Familiarity or conceptual priming: event-related potentials in name recognition. J Cogn Neurosci (2009) 2.16
Threshold-free high-power methods for the ontological analysis of genome-wide gene-expression studies. Genome Biol (2007) 1.54
[Questionable effect of antiviral therapy in malignant brain tumors]. Lakartidningen (2014) 1.38
Ultrasome: efficient aberration caller for copy number studies of ultra-high resolution. Bioinformatics (2009) 1.21
Anaerobicity prepares Saccharomyces cerevisiae cells for faster adaptation to osmotic shock. Eukaryot Cell (2004) 1.17
Isolating the retrieval of imagined pictures during episodic memory: activation of the left precuneus and left prefrontal cortex. Neuroimage (2003) 1.10
Anti-VEGF therapies for malignant glioma: treatment effects and escape mechanisms. Expert Opin Ther Targets (2009) 1.09
Full genome re-sequencing reveals a novel circadian clock mutation in Arabidopsis. Genome Biol (2011) 1.08
An improved method for detecting and delineating genomic regions with altered gene expression in cancer. Genome Biol (2008) 1.07
Look here, eye movements play a functional role in memory retrieval. Psychol Sci (2013) 1.04
Growth of language-related brain areas after foreign language learning. Neuroimage (2012) 1.03
Circadian clock components regulate entry and affect exit of seasonal dormancy as well as winter hardiness in Populus trees. Plant Physiol (2010) 1.01
Regional values of diffusional kurtosis estimates in the healthy brain. J Magn Reson Imaging (2012) 1.00
Cancer stem cells and angiogenesis. Semin Cancer Biol (2009) 0.99
Comprehensive two-dimensional gas chromatography with fast enantioseparation. Anal Chem (2002) 0.97
Metabolomic patterns in glioblastoma and changes during radiotherapy: a clinical microdialysis study. J Proteome Res (2010) 0.97
Development of an algorithm for peak detection in comprehensive two-dimensional chromatography. J Chromatogr A (2006) 0.96
A review of basic concepts in comprehensive two-dimensional gas chromatography. J Chromatogr Sci (2002) 0.95
Age-related differences in familiarity and recollection: ERP evidence from a recognition memory study in children and young adults. Cogn Affect Behav Neurosci (2005) 0.94
Cross-platform classification in microarray-based leukemia diagnostics. Haematologica (2006) 0.94
α/β oscillations indicate inhibition of interfering visual memories. J Neurosci (2012) 0.93
Effects of the VEGFR inhibitor ZD6474 in combination with radiotherapy and temozolomide in an orthotopic glioma model. J Neurooncol (2008) 0.89
Alteration of PHYA expression change circadian rhythms and timing of bud set in Populus. Plant Mol Biol (2010) 0.88
Development of a resolution metric for comprehensive two-dimensional chromatography. J Chromatogr A (2007) 0.87
Chemometrics in comprehensive multidimensional separations. Anal Bioanal Chem (2011) 0.86
Application of microscale-preparative multidimensional gas chromatography with nuclear magnetic resonance spectroscopy for identification of pure methylnaphthalenes from crude oils. J Chromatogr A (2008) 0.86
Simultaneous analysis of seven alkaloids in Coptis-Evodia herb couple and Zuojin pill by UPLC with accelerated solvent extraction. J Sep Sci (2010) 0.85
Method for small-molecule discovery based on microscale-preparative multidimensional gas chromatography isolation with nuclear magnetic resonance spectroscopy. Anal Chem (2008) 0.85
Detector technologies for comprehensive two-dimensional gas chromatography. J Sep Sci (2006) 0.85
Qualitative mass spectrometric analysis of the volatile fraction of creosote-treated railway wood sleepers by using comprehensive two-dimensional gas chromatography. J Chromatogr A (2007) 0.85
The circadian clock goes genomic. Genome Biol (2013) 0.85
The direct catalytic asymmetric alpha-aminooxylation reaction: development of stereoselective routes to 1,2-diols and 1,2-amino alcohols and density functional calculations. Chemistry (2004) 0.84
Quantification in comprehensive two-dimensional gas chromatography and a model of quantification based on selected summed modulated peaks. J Chromatogr A (2007) 0.84
Circulating biomarkers of tryptophan and the kynurenine pathway and lung cancer risk. Cancer Epidemiol Biomarkers Prev (2013) 0.84
Intentional suppression can lead to a reduction of memory strength: behavioral and electrophysiological findings. Front Psychol (2012) 0.84
Age-related changes in the control of episodic retrieval: an ERP study of recognition memory in children and adults. Dev Sci (2009) 0.84
Source-retrieval requirements influence late ERP and EEG memory effects. Brain Res (2007) 0.83
Investigating the levels and trends of organochlorine pesticides and polychlorinated biphenyl in sewage sludge. Environ Int (2010) 0.83
GC for flavonoids analysis: Past, current, and prospective trends. J Sep Sci (2012) 0.82
Methods for generating second dimension retention index data in comprehensive two-dimensional gas chromatography. J Chromatogr A (2003) 0.82
Treatment schedule is of importance when gefitinib is combined with irradiation of glioma and endothelial cells in vitro. Acta Oncol (2007) 0.82
Strategic retrieval and retrieval orientation in reality monitoring studied by event-related potentials (ERPs). Neuropsychologia (2012) 0.82
Determination of polycyclic aromatic hydrocarbons in vegetable oils using solid-phase microextraction-comprehensive two-dimensional gas chromatography coupled with time-of-flight mass spectrometry. J Chromatogr A (2007) 0.82
Headspace solid-phase microextraction--comprehensive two-dimensional gas chromatography of wound induced plant volatile organic compound emissions. Analyst (2002) 0.81
Headspace solid-phase microextraction combined with comprehensive two-dimensional gas chromatography time-of-flight mass spectrometry for the determination of volatile compounds from marine salt. J Chromatogr A (2010) 0.81
Trait anxiety, working memory capacity, and the effectiveness of memory suppression. Scand J Psychol (2010) 0.81
Multiple component isolation in preparative multidimensional gas chromatography with characterisation by mass spectrometry and nuclear magnetic resonance spectroscopy. J Chromatogr A (2009) 0.81
Application of comprehensive two-dimensional gas chromatography to sterols analysis. J Chromatogr A (2008) 0.81
Enantiomeric separation and quantification of ephedrine-type alkaloids in herbal materials by comprehensive two-dimensional gas chromatography. J Chromatogr A (2006) 0.81
PTPN6 expression is epigenetically regulated and influences survival and response to chemotherapy in high-grade gliomas. Tumour Biol (2014) 0.80
"Do you see yonder cloud?"--On priming concepts, a new test, and a familiar outcome. Reply to Lucas et al.: "Familiarity or conceptual priming? Good question! Comment on Stenberg, Hellman, Johansson, and Rosén (2009)". J Cogn Neurosci (2010) 0.80
Characterization of biodiesel and biodiesel blends using comprehensive two-dimensional gas chromatography. J Sep Sci (2008) 0.80
Organophosphorus pesticide and ester analysis by using comprehensive two-dimensional gas chromatography with flame photometric detection. J Hazard Mater (2013) 0.80
Ultranet: efficient solver for the sparse inverse covariance selection problem in gene network modeling. Bioinformatics (2012) 0.80
Electrophysiological correlates of retrieval orientation in reality monitoring. Neuroimage (2010) 0.80
Evaluation of World Anti-Doping Agency criteria for anabolic agent analysis by using comprehensive two-dimensional gas chromatography-mass spectrometry. Anal Bioanal Chem (2010) 0.80
Modulation ratio in comprehensive two-dimensional gas chromatography. Anal Chem (2006) 0.80
LRIG1 is a prognostic biomarker in non-small cell lung cancer. Acta Oncol (2015) 0.80
Novel hybrid comprehensive 2D-multidimensional gas chromatography for precise, high-resolution characterization of multicomponent samples. Anal Chem (2012) 0.79
Investigation of folic acid stability in fortified instant noodles by use of capillary electrophoresis and reversed-phase high performance liquid chromatography. J Chromatogr A (2008) 0.79
Frontotemporal hypoactivity during a reality monitoring paradigm is associated with delusions in patients with schizophrenia spectrum disorders. Cogn Neuropsychiatry (2013) 0.79
Early ERP Signature of Hearing Impairment in Visual Rhyme Judgment. Front Psychol (2013) 0.79
Enigma of a rapid introduction of antiangiogenic therapy with bevacizumab in glioblastoma: a new era in the treatment of malignant brain tumours? Acta Oncol (2009) 0.79
Conceptual and perceptual memory: retrieval orientations reflected in event-related potentials. Acta Psychol (Amst) (2006) 0.79
Multidimensional gas chromatography beyond simple volatiles separation. Chem Commun (Camb) (2014) 0.79
Investigating the distribution of polybrominated diphenyl ethers through an Australian wastewater treatment plant. Sci Total Environ (2010) 0.79
Chemical signature of ecstasy volatiles by comprehensive two-dimensional gas chromatography. Forensic Sci Int (2011) 0.78
Characterisation of capillary ionic liquid columns for gas chromatography-mass spectrometry analysis of fatty acid methyl esters. Anal Chim Acta (2013) 0.78
Determination of volatile compounds in Brazilian distilled cachaça by using comprehensive two-dimensional gas chromatography and effects of production pathways. J Chromatogr A (2008) 0.78
Electrophysiological correlates of competitor activation predict retrieval-induced forgetting. Cereb Cortex (2013) 0.78
A prospective study of one-carbon metabolism biomarkers and cancer of the head and neck and esophagus. Int J Cancer (2014) 0.78
Quantification of polycyclic aromatic hydrocarbons based on comprehensive two-dimensional gas chromatography-isotope dilution mass spectrometry. J Chromatogr A (2008) 0.78
Universal method for online enrichment of target compounds in capillary gas chromatography using in-oven cryotrapping. Anal Chem (2011) 0.78
Comparison of odor-active compounds in the spicy fraction of hop (Humulus lupulus L.) essential oil from four different varieties. J Agric Food Chem (2007) 0.78
How does testing affect retrieval-related processes? An event-related potential (ERP) study on the short-term effects of repeated retrieval. Cogn Affect Behav Neurosci (2015) 0.78
Chemical characterisation of two Australian-grown strawberry varieties by using comprehensive two-dimensional gas chromatography-mass spectrometry. Food Chem (2013) 0.78
Characterization of glucose transport mutants of Saccharomyces cerevisiae during a nutritional upshift reveals a correlation between metabolite levels and glycolytic flux. FEMS Yeast Res (2007) 0.77
Associative learning measured with ERP predicts deferred imitation using a strict observation only design in 14 to 15 month old children. Scand J Psychol (2013) 0.77
Metabolic profiling of infant urine using comprehensive two-dimensional gas chromatography: Application to the diagnosis of organic acidurias and biomarker discovery. J Chromatogr A (2009) 0.77
Positional and geometric isomer separation of FAME by comprehensive 2-D GC. Lipids (2002) 0.77
The combination of gas chromatography-olfactometry and multidimensional gas chromatography for the characterisation of essential oils. J Chromatogr A (2006) 0.77
Large-volume stacking with polarity switching and sweeping for chlorophenols and chlorophenoxy acids in capillary electrophoresis. Electrophoresis (2003) 0.77
Efficient and selective sulfoxidation by hydrogen peroxide, using a recyclable flavin--[BMIm]PF6 catalytic system. J Org Chem (2006) 0.77
Peak modeling approach to accurate assignment of first-dimension retention times in comprehensive two-dimensional chromatography. Anal Chem (2009) 0.77
Comprehensive two-dimensional gas chromatography improves separation and identification of anabolic agents in doping control. J Chromatogr A (2009) 0.77
Variation of zeta-potential with temperature in fused-silica capillaries used for capillary electrophoresis. Electrophoresis (2006) 0.77
Inflammatory Cytokines and Lung Cancer Risk in 3 Prospective Studies. Am J Epidemiol (2016) 0.76
Metal-organic frameworks as stationary phases for mixed-mode separation applications. Chem Commun (Camb) (2014) 0.76
Accelerating analysis for metabolomics, drugs and their metabolites in biological samples using multidimensional gas chromatography. Bioanalysis (2009) 0.76
Simple preparative gas chromatographic method for isolation of menthol and menthone from peppermint oil, with quantitative GC-MS and (1) H NMR assay. J Sep Sci (2011) 0.76
Rapid sequential separation of essential oil compounds using continuous heart-cut multi-dimensional gas chromatography-mass spectrometry. J Chromatogr A (2011) 0.76
Identification of potent odourants in wine and brewed coffee using gas chromatography-olfactometry and comprehensive two-dimensional gas chromatography. J Chromatogr A (2011) 0.76
Strategic retrieval in a reality monitoring task. Neuropsychologia (2011) 0.76
ERP correlates of target-distracter differentiation in repeated runs of a continuous recognition task with emotional and neutral faces. Brain Cogn (2010) 0.76
Anthropometry and the Risk of Lung Cancer in EPIC. Am J Epidemiol (2016) 0.76
One-pot microwave derivatization of target compounds relevant to metabolomics with comprehensive two-dimensional gas chromatography. J Chromatogr B Analyt Technol Biomed Life Sci (2010) 0.76
Retention time reproducibility in comprehensive two-dimensional gas chromatography using cryogenic modulation an intralaboratory study. J Chromatogr A (2002) 0.76
Quantitative preparative gas chromatography of caffeine with nuclear magnetic resonance spectroscopy. J Sep Sci (2013) 0.75